Allopurinol effects on residual renal function in end-stage renal disease patients undergoing peritoneal dialysis: Randomized controlled trial
Objective: There is increasing evidence to show that hyperuricemia may have a pathogenic role in the progression of renal diseases. We performed a prospective, randomized, controlled trial to investigate the renal effects of allopurinol treatment in hyperuricemic patients with end-stage renal diseas...
Saved in:
Main Authors: | Firouzeh Moeinzadeh (Author), Elham Kabiri Naeini (Author), Mojgan Mortazavi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lived Experiences of End Stage Renal Disease Patients Undergoing Continuous Ambulatory Peritoneal Dialysis Therapy
by: M. Hanif Prasetya 'Adhi, et al.
Published: (2021) -
Torus palatinus in end-stage renal disease patients receiving peritoneal dialysis: Does renal osteodystrophy play a role?
by: Yildiray Sisman, et al.
Published: (2012) -
Associated factors for depressive disorder in patients with end-stage renal disease treated with continuous ambulatory peritoneal dialysis
by: Traisathit P, et al.
Published: (2019) -
MICROBIOLOGICAL SPECTRUM IN CASE OF TENCKHOFF CATHETER EXIT SITE INFECTION AT PERITONEAL DIALYSIS IN PATIENTS WITH END-STAGE RENAL DISEASE
by: Y. Zavodovskyi
Published: (2015) -
Omega-3 supplementation improves pruritus in continuous ambulatory peritoneal dialysis patients: A crossover randomized pilot clinical trial
by: Arian Pourmehdi Lahiji, et al.
Published: (2018)